NCT05168436View on ClinicalTrials.gov

A Study of Preferences of Participants and Oncologists for the Characteristics of the Treatment for Renal Cell Carcinoma (RCC) In Spain And Portugal

CompletedOBSERVATIONAL
Enrollment

105

Participants

Timeline

Start Date

August 5, 2019

Primary Completion Date

July 13, 2020

Study Completion Date

July 13, 2020

Conditions
Renal Cell Carcinoma
Trial Locations (1)

12071

Local Institution, Castellon

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT05168436 - A Study of Preferences of Participants and Oncologists for the Characteristics of the Treatment for Renal Cell Carcinoma (RCC) In Spain And Portugal | Biotech Hunter | Biotech Hunter